✦ LIBER ✦

Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

✍ Scribed by Betty S. Pio; Cecilia K. Park; Richard Pietras; Wei-Ann Hsueh; Nagichettiar Satyamurthy; Mark D. Pegram; Johannes Czernin; Michael E. Phelps; Daniel H. S. Silverman

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 312 KB
Volume: 8
Category: Article
ISSN: 1536-1632
DOI: 10.1007/s11307-005-0029-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting the prognoses of breast carci

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

✍ Masaki Oshida; Kimiichi Uno; Masato Suzuki; Takeshi Nagashima; Hideyuki Hashimot 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## BACKGROUND. Positron emission tomography (PET) with 2-deoxy-2-fluoro[ 18 F]-Dglucose (FDG) can provide quantitative information about tumor glucose metabolism. The prognostic value of this technique was evaluated for breast carcinoma patients. ## METHODS. FDG PET was performed on 70 patients w

Potential impact of [18F]3'-deoxy-3'-flu

Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

✍ D. L. Francis; D. Visvikis; D. C. Costa; T. H. A. Arulampalam; C. Townsend; S. K 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 263 KB

Monitoring response to therapy in cancer

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods

✍ C. J. Hoekstra; I. Paglianiti; O. S. Hoekstra; E. F. Smit; P. E. Postmus; G. J. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 72 KB

Evaluation of chemotherapy response in p

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m

The clinical application of 18F-fluorode

The clinical application of 18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

✍ Hiroyuki Kato; Masanobu Nakajima; Makoto Sohda; Naritaka Tanaka; Takanori Inose; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Positron emission tomography with 18F-fl

Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer

✍ A. David McCollum; Steven C. Burrell; Robert I. Haddad; Charles M. Norris; Roy B 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract ## Background. Conventional imaging is limited in identifying persistent disease after organ‐preserving therapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). We studied the accuracy of positron emission tomography (PET) with ^18^F‐fluoro‐2‐deoxy‐D‐glu